Replies to post #705 on UMeWorld, Ltd. (ALRXF)

[jackfree]

I was until today. I used to post on another Investor Board agoracom.com However ALRX stopped paying them and the board was blocked. I having been following ALRX for years and I hope they can get support for Indaflex again. It seemed to be a great product and made it to Phase II. They do have other products so we shall wait and see.

HONG KONG, May 10 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX.OB), has been advised by Cypress Biosciences ("Cypress"), its development partner for Indaflex, that Cypress is not funding development of Indaflex. Notwithstanding to the termination of all Indaflex activity in the U.S.A., AlphaRx continues to develop Indaflex for the Chinese market. AlphaRx is working diligently with its regulatory consultants in the preparation for submission of a CTA (clinical Trial Application) with the China SFDA in order to begin human trials in China. These preparations are proceeding on schedule.